Defensive by Design: Munich Re Turns Down Growth to Protect Margins as Insiders Step In
17.05.2026 - 02:54:44 | boerse-global.de
With a Solvency II ratio of 292% — one of the highest in the European reinsurance sector — Munich Re is in no position of weakness. But rather than chase market share at any price, the company is deliberately pulling back capacity, a move that has unsettled investors even as profits surge.
First-quarter net profit jumped 57% to €1.714 billion, from €1.094 billion a year earlier, driven primarily by a benign natural catastrophe environment. The underwriting result in property and casualty (P&C) reinsurance climbed to €2.676 billion, and the combined ratio improved sharply to 66.8% from 83.9%. Those are numbers most rivals would envy. Yet the stock closed last week at €475.10, within a whisker of its year low, having shed 5.7% over the week and nearly 16% over the past 30 days.
The disconnect stems from the April renewal season, where Munich Re accepted an 18.5% drop in written volume and a 3.1% decline in P&C pricing. Analysts at Barclays flagged the magnitude of the contraction as "surprisingly sharp," especially compared with Swiss Re, which saw only a mild dip, and Hannover Rück, which actually expanded its book. Post-earnings, several banks trimmed their price targets: RBC to €490, Citi to €511 and Berenberg to €565, while maintaining neutral ratings.
Should investors sell immediately? Or is it worth buying Münchener Rück?
Management, however, is sending a different signal. Chief Financial Officer Andrew Buchanan bought shares at an average price of around €467 on May 13, and board members Achim Kassow and Stefan Golling have also deployed their own capital recently. The insider buying comes against a backdrop of a €2.25 billion share buyback program that kicked off on April 29, underscoring the board's conviction that the stock is undervalued.
The primary insurance subsidiary ERGO provides an additional buffer. It contributed €235 million to group profit in the first quarter and is in the midst of a restructuring that targets €600 million in annual savings by 2030, partly through artificial intelligence and process automation. A leaner ERGO reduces Munich Re's reliance on volatile large-loss events in reinsurance and offers a more predictable earnings stream.
Technically, the stock now trades roughly 11% below its 50-day moving average. Chart watchers are eyeing the €486.90 resistance zone as the first hurdle for any sustained recovery. Until then, the market appears to be weighing whether the company's disciplined underwriting approach is a long-term strength or a short-term growth drag.
All eyes now turn to July renewals, where pricing momentum will be tested. Munich Re is sticking to its full-year profit target of €6.3 billion for 2026, and the next hard data point arrives on August 7 with second-quarter results. In the meantime, the boardroom's willingness to put cash on the line at current levels may prove the most telling signal of all.
Ad
Münchener Rück Stock: New Analysis - 17 May
Fresh Münchener Rück information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Defensive Aktien ein!
Für. Immer. Kostenlos.
